Kidney, Bladder & Prostate Cancer Translational Research Disease Group

Understanding the genetic alterations that lead to kidney, bladder and prostate cancer is essential to fighting the disease. At Fox Chase, a multidisciplinary team of researchers and clinicians meets regularly to review translational research initiatives to identify and characterize new biomarkers of kidney, bladder and prostate cancers that lead to new, innovative prevention and targeted therapy options for our patients.